In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

NEED HELP?

Read the Frequently Asked Questions for a better use

READ MORE

 

Refine your search
Sponsor

ESC Congress 365

Your free access to ESC Congress content all year long 

The online library to view thousands of videos, slides, abstracts and reports from the world's largest cardiovascular event – anytime & without subscription!

To make the most of it watch the tutorial video or check out the FAQ!

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by Boehringer Ingelheim.

Boehringer Ingelheim
Abstract Slides/e-posters Video Report Interview
 
Reversal agents for NOACs: what's available and how do they work?
Presenter: J Halperin (New York,US), J Weitz (Hamilton,CA), J Eikelboom (Hamilton,CA)
2016
more
 
Immediate reversal of dabigatran with idarucizumab: our clinical experience.
Presenter: C Pollack (Philadelphia,US), R Deo (Philadelphia,US), P Verhamme (Leuven,BE)
2016
more
 
Factors influencing OAC choice post STEMI.
Presenter: L De Luca (Roma,IT), G Nickenig (Bonn,DE)
2016
more
 
NOACs: where are we going?
Presenter: J Eikelboom (Hamilton,CA)
2016
more
 
Anticoagulation in the electrophysiology lab: how can specific reversal simplify care?
Presenter: H Calkins (Baltimore,US)
2016
more
 
A specific reversal agent for dabigatran is available: should you have it in your electrophysiology lab?
Presenter: H Calkins (Baltimore,US), R Deo (Philadelphia,US)
2016
more
 
The future is now.
Presenter: C P Cannon (Boston,US)
2016
more
 
Panel debate: impact of a specific reversal agent on your practice.
Presenter: J Halperin (New York,US), H Buller (Amsterdam,NL)
2016
more
 
Cardiac emergencies: how can a reversal agent for a NOAC impact practice?
Presenter: J Halperin (New York,US), D Erlinge (Lund,SE), R Whitlock (Hamilton,CA)
2016
more
 
Management of bleeding and emergency procedures in anticoagulated patients.
Presenter: C Pollack (Philadelphia,US)
2015
more

The scientific Programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Boehringer Ingelheim Boehringer Ingelheim